D.Fenstec Srl, based in Altavilla Vicentina (Vicenza), is a company with years of experience in the wellness industry.
Thanks to an idea of the managing director Gaetano Bertinato, the company has developed an innovative product, based on clinical research, which is able to relieve pain without the use of drugs or thermal shock. It is a Class I Medical Device with a large number of potential applications.
FIT’s mission is supported by a Scientific Committee whose members include lecturers at leading Italian universities, and acclaimed medical practitioners who carry out international research, release scientific publications and work to expand FIT’s field of application. They are all committed to resolving issues that affect the majority of people.
Thanks to its many developments, FIT currently retails in more than 30 countries including Switzerland, Scandinavia, Lebanon, South Africa, India, Ghana, Kenya and the UAE, but a rapidly growing number of countries are continuing to invest in our products.
Initially, the need for FIT came from an awareness that the biominerals normally used in existing technologies were only aimed at thermal regulation. Tests and research have shown that the human body emits and receives infrared waves, which can eliminate the toxins that are one of the main causes of inflammation and pain. These studies led to the D.Fenstec concept, resulting in a solution that exploits the capacity of far infrared electromagnetic waves.
The technology looks to have enormous application potential. In addition to pain relief, applying, FIT has benefits that range from improving circulatory conditions to boosting microcirculation and better muscle efficiency, by implementing physical endurance and the ability of the body to readjust in functionally deficient conditions.
Recent research coordinated by prof. Ricci with the University of Verona has also demonstrated how using FIT increases an individual’s stability considerably, with a resulting improvement in locomotor system coordination and balance. FIT is also currently being used by prof. Palombi in the treatment of diabetic ulcers.